Vertex Pharmaceuticals Inc (VRTX)
287.32
+5.53 (+1.96%)
USD |
NASDAQ |
Jul 01, 16:00
287.30
-0.02 (-0.01%)
After-Hours: 20:00
Vertex Pharmaceuticals Shareholders Equity (Quarterly): 10.91B for March 31, 2022
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2022 | 10.91B |
December 31, 2021 | 10.10B |
September 30, 2021 | 9.531B |
June 30, 2021 | 9.196B |
March 31, 2021 | 8.980B |
December 31, 2020 | 8.687B |
September 30, 2020 | 8.133B |
June 30, 2020 | 7.519B |
March 31, 2020 | 6.462B |
December 31, 2019 | 6.085B |
September 30, 2019 | 5.253B |
June 30, 2019 | 5.070B |
March 31, 2019 | 4.723B |
December 31, 2018 | 4.435B |
September 30, 2018 | 2.906B |
June 30, 2018 | 2.686B |
March 31, 2018 | 2.401B |
December 31, 2017 | 2.029B |
September 30, 2017 | 1.791B |
June 30, 2017 | 1.671B |
March 31, 2017 | 1.500B |
December 31, 2016 | 1.157B |
September 30, 2016 | 1.022B |
June 30, 2016 | 981.35M |
March 31, 2016 | 957.08M |
Date | Value |
---|---|
December 31, 2015 | 939.97M |
September 30, 2015 | 922.15M |
June 30, 2015 | 894.96M |
March 31, 2015 | 976.46M |
December 31, 2014 | 1.075B |
September 30, 2014 | 1.156B |
June 30, 2014 | 1.172B |
March 31, 2014 | 1.231B |
December 31, 2013 | 1.356B |
September 30, 2013 | 1.265B |
June 30, 2013 | 1.322B |
March 31, 2013 | 746.12M |
December 31, 2012 | 999.18M |
September 30, 2012 | 1.028B |
June 30, 2012 | 1.038B |
March 31, 2012 | 930.50M |
December 31, 2011 | 786.84M |
September 30, 2011 | 579.76M |
June 30, 2011 | 307.55M |
March 31, 2011 | 391.67M |
December 31, 2010 | 503.97M |
September 30, 2010 | 650.10M |
June 30, 2010 | 827.14M |
March 31, 2010 | 990.61M |
December 31, 2009 | 1.096B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.791B
Minimum
Sep 2017
10.91B
Maximum
Mar 2022
6.152B
Average
6.085B
Median
Dec 2019
Shareholders Equity (Quarterly) Benchmarks
Moderna Inc | 17.08B |
Eli Lilly and Co | 9.331B |
Bristol-Myers Squibb Co | 31.58B |
AbbVie Inc | 16.28B |
Regeneron Pharmaceuticals Inc | 19.91B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 14.26B |
Total Liabilities (Quarterly) | 3.349B |
Current Ratio | 4.752 |